Published by Iain Gilbert on 4th September 2017
(ShareCast News) - Clinical antibody specialist Bioventix expects revenues and pre-tax profits to be ahead of market projections for the year after its revenue increased by almost a quarter.
URL: http://www.digitallook.com/dl/news/story/26390512/...